Novel	O
protein	B:C0033684
-	O
inhibitor	B:C0243077
interactions	O
in	O
site	B:C3658228
3	I:C3658228
of	I:C3658228
Ca(	I:C3658228
2	I:C3658228
+	I:C3658228
)	I:C3658228
-	I:C3658228
bound	I:C3658228
S100B	I:C3658228
as	O
discovered	O
by	O
X	B:C0206755
-	I:C0206755
ray	I:C0206755
crystallography	I:C0206755
Structure	B:C0920472
-	I:C0920472
based	I:C0920472
drug	I:C0920472
discovery	I:C0920472
is	O
under	O
way	O
to	O
identify	O
and	O
develop	O
small	B:C1328819
-	I:C1328819
molecule	I:C1328819
S100B	B:C3658228
inhibitors	B:C0243077
(	O
SBiXs	B:C0243077
)	O
.	O

Such	O
inhibitors	B:C0243077
have	O
therapeutic	O
potential	O
for	O
treating	O
malignant	B:C0025202
melanoma	I:C0025202
,	O
since	O
high	O
levels	O
of	O
S100B	B:C3658228
downregulate	B:C0013081
wild	B:C0080055
-	I:C0080055
type	I:C0080055
p53	I:C0080055
tumor	B:C1325410
suppressor	I:C1325410
function	I:C1325410
in	O
this	O
cancer	B:C0025202
.	O

Computational	O
and	O
X	B:C0206755
-	I:C0206755
ray	I:C0206755
crystallographic	I:C0206755
studies	I:C0206755
of	O
two	O
S100B	B:C3658228
-	O
SBiX	B:C0243077
complexes	B:C1704241
are	O
described	O
,	O
and	O
both	O
compounds	O
(	O
apomorphine	B:C0237406
hydrochloride	I:C0237406
and	O
ethidium	B:C0019873
bromide	I:C0019873
)	O
occupy	O
an	O
area	O
of	O
the	O
S100B	B:C3658228
hydrophobic	O
cleft	B:C0205242
which	O
is	O
termed	O
site	B:C0205675
3	I:C0205675
.	O

These	O
data	O
also	O
reveal	O
novel	O
protein	B:C0033684
-	O
inhibitor	B:C0243077
interactions	O
which	O
can	O
be	O
used	O
in	O
future	O
drug	O
-	O
design	O
studies	O
to	O
improve	B:C0184511
SBiX	B:C0243077
affinity	O
and	O
specificity	O
.	O

Of	O
particular	O
interest	O
,	O
apomorphine	B:C0237406
hydrochloride	I:C0237406
showed	O
S100B	B:C3658228
-	O
dependent	O
killing	B:C0599733
in	O
melanoma	B:C1513095
cell	I:C1513095
assays	B:C1510438
,	O
although	O
the	O
efficacy	O
exceeds	O
its	O
affinity	O
for	O
S100B	B:C3658228
and	O
implicates	O
possible	O
off	O
-	O
target	O
contributions	O
.	O

Because	O
there	O
are	O
no	O
structural	O
data	O
available	O
for	O
compounds	O
occupying	O
site	B:C0205675
3	I:C0205675
alone	O
,	O
these	O
studies	B:C2603343
contribute	O
towards	O
the	O
structure	O
-	O
based	O
approach	O
to	O
targeting	O
S100B	B:C3658228
by	O
including	O
interactions	O
with	O
residues	O
in	O
site	B:C0205675
3	I:C0205675
of	O
S100B	B:C3658228
.	O

